Abstract Adipophilin (ADPH), a member of the perilipin family of lipid droplet-associated proteins, is hypothesized to mediate milk lipid formation and secretion. Unexpectedly, the fat content of milk from ADPH-null mice was only modestly lower than that of wild-type controls, and neither TIP47 nor perilipin appeared to fully compensate for ADPH loss. This prompted us to investigate the possibility that the mutated ADPH gene was not a genuine null mutation. ADPH transcripts were detected in ADPH-null mammary tissue by quantitative real-time PCR, and C-terminal-specific, but not N-terminal-specific, ADPH antibodies detected a single lower molecular weight product and immunostained cytoplasmic lipid droplets (CLDs) and secreted milk fat globules in ADPH-null mammary tissue. Furthermore, stable cell lines expressing cDNA constructs corresponding to the ADPH-null mutation produced a product comparable in size to the one detected in ADPH-null mammary glands and localized to CLDs. Based on these data, we conclude that ADPH-null mice express an N-terminally truncated form of ADPH that retains the ability to promote the formation and secretion of milk lipids.-Russell, T.
A large body of evidence suggests that proteins located on the surface of cytoplasmic lipid droplets (CLDs) play important roles in lipid storage, trafficking, and secretion (1, 2) . Although the physiological roles of apolipoproteins in the formation and secretion of lipoprotein particles are well established, much less is known about the proteins and processes that mediate CLD formation and secretion. The PAT (for perilipin, adipophilin, and TIP47) family of CLD-associated proteins are attractive candidates as regulators of lipid storage and secretion in the mammary gland (3) (4) (5) . Perilipin expression appears to be limited to adipose and steroidogenic tissue (6) , whereas adipophilin (ADPH) and TIP47 are ubiquitously expressed in a wide range of tissue types (7) (8) (9) . TIP47 was originally coidentified as a 48 kDa placental protein 17b, or PP17b (10, 11) , and an endosomal trafficking guide for mannose 6-phosphate receptors (12) ; however, subsequent studies have demonstrated that it can also bind to CLD (13) . In addition, it has been reported to be associated with milk fat globules in human milk (14) . ADPH is hypothesized to play a key role in CLD formation: it localizes to CLDs in many mammalian cell types, including mammary epithelial cells (5, 7, 8, 15, 16) , and cellular levels of ADPH have been shown to correlate with lipid accumulation in a variety of cells and tissues (17) (18) (19) (20) (21) (22) (23) . We have shown that ADPH is selectively expressed by secretory epithelial cells in the mouse mammary gland and that its expression is developmentally linked to CLD accumulation during the differentiation of the mammary gland into a secretory organ during the last half of pregnancy (5) . Evidence of functional redundancy among members of the PAT family in CLD formation and metabolism (24, 25) further underscores the importance of these proteins in CLD function. The lactating mammary gland continuously generates and secretes CLDs, and lipids are a substantial component of the milk of most species; for this reason, this system provides a sensitive physiological model to investigate the regulation of CLD formation and secretion.
In many species, including mice, the lactating mammary gland is one of the most active lipogenic organs in the body (26, 27) . The mouse mammary gland is a particularly ideal model because most of its development occurs after birth. Specifically, pubertal hormones stimulate the formation of tree-like ductal structures that extend from the nipple into the mammary fat pad (28) . The milk-secreting units, called alveoli, originate from these structures; they grow and mature during pregnancy into grape-like clusters of epithelial cells that, at parturition, become highly secretory (29) . These cells actively produce and secrete lipids into the alveolar lumina by a distinct multistep process. Milk lipids originate from triglycerides and cholesteryl esters synthesized by endoplasmic reticulumassociated enzymes and are released into the cytoplasm as protein-coated CLDs (4) . In a unique secretion process, the CLDs move toward the apical membrane, contacting and becoming progressively enveloped by this structure (3, 30) before being released into the lumina as membrane-coated structures known as milk fat globules. Despite the nutritional importance of milk lipids and the prominence of lipid biogenesis and secretion in the function of alveolar epithelial cells, the factors regulating the formation and secretion of CLDs remain poorly defined.
In this study, we use the differentiating mammary gland to test the hypothesis that ADPH regulates CLD formation, accumulation, and secretion by comparing these processes in wild-type (WT) mice and mice believed to lack ADPH (31). Our results show that CLD accumulated in secretory epithelial cells during the differentiation of mammary glands of putative ADPH-null mice and that the milk fat content of these mice was only modestly lower than that of WT mice. In the course of characterizing the basis for the modest lactation phenotype observed in ADPH-null animals, we found that these mice express an N-terminally truncated form of ADPH that may play a role in milk lipid formation. Possible compensatory functional roles of truncated ADPH and TIP47 in the accumulation and secretion of CLD are investigated in differentiating and lactating mouse mammary tissue.
MATERIALS AND METHODS

Animals and tissue preparation
B6.129-Adfp tm1Chan mice deficient in ADPH were generated as described previously (31) . WT C57B6 mice were obtained from Jackson Laboratories. Both strains were maintained as breeding colonies in the Animal Resource Center of the University of Colorado Health Sciences Center (UCHSC) and housed individually. Pregnancy was timed by the observation of vaginal plugs after mating. The first day of pregnancy was taken as the day of vaginal plug detection. Parturition occurs on approximately day 19 of pregnancy; the day of birth is also designated as day 1 of lactation. Mammary tissue was removed from animals euthanized by carbon dioxide at the times indicated in the text and flash-frozen in liquid nitrogen or processed for immunofluorescence microscopy (5, 32) . All animal procedures were approved by the Institutional Animal Care and Use Committee of the UCHSC.
Antibodies
Antibodies to amino acids 1-25 of murine ADPH (N-terminalspecific ADPH antibodies) were generated in rabbits (5) or were obtained commercially (guinea pig anti-ADPH; Research Diagnostics, Inc./Fitzgerald Industries International, Flanders NJ). Antibodies to amino acids 409-425 of murine ADPH (C-terminalspecific ADPH antibodies) were generated in rabbits (Global Peptides, Fort Collins, CO). Antibodies to amino acids 1-16 of murine TIP47 (Affinity Bioreagents, Golden, CO) were described previously (5) . Guinea pig antibodies to perilipin were obtained commercially (Research Diagnostics/Fitzgerald Industries). The specificities of ADPH and TIP47 antibodies were established by competition assays using specific immunizing peptides in both Western blot and immunofluorescence assays and by the absence of reaction of anti-ADPH and anti-TIP47 with purified recombinant mouse TIP47 and ADPH proteins, respectively, using Western analysis (data not shown).
Protein extraction and immunoblot analysis
Mammary tissue was ground under liquid nitrogen using a mortar and pestle and extracted by methanol/chloroform as described previously (5) . Precipitated protein was rinsed with methanol, dried, suspended in 10% SDS solution, and stored at 280jC before use. Proteins (10 mg) from mammary gland extracts were separated on 10% polyacrylamide gels and transferred to nitrocellulose membranes. ADPH was detected using either rabbit or guinea pig anti-ADPH at 1:1,000 dilution. TIP47 was detected using rabbit anti-TIP47 at 1:2,000 dilution. Corresponding horseradish peroxidase-conjugated secondary antibodies (Sigma Chemical Co., St. Louis, MO) were used according to the manufacturer's specifications. Western Lightening Chemiluminescence Reagent (Perkin-Elmer, Boston, MA) was used to detect bands, and band intensities were quantified by densitometry (ChemiDoc system; Bio-Rad, Hercules, CA). Protein standards were used at varying dilutions to verify that the densitometry responses of each protein were in the linear range.
Isolation and quantification of mRNA
Total RNA was extracted from frozen tissue using Trizol (Life Technologies) according to the manufacturer's instructions. The purity, concentration, and integrity of total RNA from each sample were verified using a NanoDrop spectrophotometer (NanoDrop Technologies, Wilmington, DE) and the RNA 6000 Nano Assay (Agilent Technologies, Palo Alto, CA) in the UCHSC Cancer Core. ADPH and TIP47 transcript copy numbers were determined by quantitative real-time (QRT)-PCR analysis using a multiplexing strategy to provide an internal standard for normalization (b 2 -microglobulin). QRT-PCR assays were performed in the Quantitative Genomics Core Laboratory at the University of Texas Health Sciences Center. Primers and probes are listed in Table 1 . All QRT-PCR assays used were validated at the Quantitative Genomics Core Laboratory to ensure that they passed the minimum requirements for efficiency, sensitivity, and selectivity. At least three tissue replicates at each time point were analyzed at least twice with similar results.
Cell lines
Plasmids containing cDNA encoding full-length murine ADPH with a C-terminal vesicular stomatitis virus glycoprotein (VSVG) epitope (pADPH[FL]VSV) were described previously (33) . Plasmids containing cDNA encoding an open reading frame similar to that of ADPH D2,3 mice with a C-terminal VSVG epitope tag were generated by PCR amplification of pADPH[FL]VSV using forward (5 ¶-TAAAGCTTATTGCGGTTGCCAATACCTAT-3 ¶) and reverse (5 ¶-GATGTCGACCTATAGAATAGGGCCCTC-3 ¶) primers containing Hind III (underlined in the forward primer) and SalI (underlined in the reverse primer) restriction sites. (33) . Transfected cells were selected with G418 (50 mg/ml) and cloned by limiting dilution through two rounds and cultured in DMEM containing high glucose and supplemented with 6% bovine calf serum. Immunolocalization studies were carried out in cultures incubated in medium containing 300 mM oleic acid.
Immunofluorescence microscopy
Freshly dissected mouse mammary tissue was fixed by overnight incubation in neutral buffered saline and embedded in paraffin at the UCHSC Pathology Core facility. Microtome sections (8 mm) were mounted on glass slides, deparaffinized and hydrated, and subjected to antigen retrieval (Vector Laboratories) as described previously (32) . The sections were then permeabilized in 0.2% glycine in PBS, blocked with 5% normal goat serum and 0.1% (w/v) saponin in PBS overnight at 4jC, and incubated with primary antibodies at the following dilutions for 1 h at room temperature: C-terminal-specific ADPH, 1:100; rabbit or guinea pig N-terminal-specific ADPH, 1:100; TIP47, 1:200; and perilipin, 1:100. Immunolabeled proteins were detected with Alexa Fluor: 594-labeled donkey anti-rabbit IgG or donkey anti-guinea pig IgG (Invitrogen/Molecular Probes, Carlsbad, CA). The luminal borders of mammary alveoli were identified by staining with Alexa Fluor: 488 conjugated to wheat germ agglutinin (Invitrogen/Molecular Probes), and nuclei were identified by 4 ¶,6-diamidino-2-phenylindole staining as described (5) .
Cultured cells, grown on glass coverslips, were fixed in 3.7% formalin for 10 min, extracted with 50% ethanol for 4 min, and washed in PBS for 30 min. Expressed forms of ADPH were detected by labeling with mouse anti-VSVG antibodies (1 mg/ml) in conjunction with Alexa Fluor: 594-labeled secondary antibodies (Invitrogen/Molecular Probes). Nuclei were stained with 4 ¶,6-diamidino-2-phenylindole.
Digital confocal images were captured on a Nikon Eclipse 80i microscope, equipped with a RETIGA 2000R Fast cooled video camera and Nomarski optics, using a 603 objective and NIS Elements imaging software. Fluorescent images were digitally deconvolved using the No Neighbors algorithm and converted to TIFF files.
RESULTS
Loss of ADPH decreases milk fat
The functional importance of ADPH in the formation and secretion of milk lipids was initially investigated by comparing milk fat content from WT and ADPH-null mice. At midlactation [postcoital day (PCD) 29], the fat content (vol%) of milk from ADPH -null mice (24.2 6 1.7%) was 12% lower than that of WT mice (27.4 6 1.1%). Although this difference is statistically significant (P , 0.0001; n 5 10), these data suggested that either ADPH has only a modest role in the production and/or secretion of milk lipids or another protein compensated for ADPH in these processes. Because TIP47 is structurally similar to ADPH (34), we hypothesized that it could functionally compensate for ADPH with regard to lipid droplet formation and secretion in mammary epithelial cells.
TIP47 replaces ADPH on CLDs in ADPH-null mice
In previous studies, TIP47 was shown to substitute for ADPH in the formation of CLDs in fibroblasts from ADPH-null mice (25) . To determine whether other PAT proteins substitute for ADPH in milk lipid formation and/ or secretion in ADPH-null mice, we immunostained mammary gland sections from WT and ADPH-null mice for ADPH, TIP47, and perilipin ( Fig. 1 ). In agreement with previous studies (5), ADPH immunostaining specifically localized to CLDs in secretory epithelial cells of WT mammary glands (Fig. 1A , panel a), whereas TIP47 staining was detected as diffusely distributed punctate structures (Fig. 1A , panel b) and perilipin staining was restricted to a few small islands of lipid-depleted adipose tissue that remain in the mammary gland during lactation (Fig. 1A , panel c). As expected, we did not detect ADPH immunostaining in mammary glands of ADPH-null mice using N-terminal-specific ADPH antibodies (Fig. 1B, panel a) . However, in contrast to WT glands, TIP47-positive CLDs were detected in secretory epithelial cells of ADPH-null mice (Fig. 1B, panel b) , although the staining was patchy and some CLDs did not appear to possess TIP47. As in WT mice, perilipin staining was detected only in adipose tissue in mammary glands of ADPH-null mice. These results are consistent with the findings of Sztalryd et al. (25) in fibroblasts, showing that TIP47 localizes to CLDs in ADPH-deficient mice, and raise the possibility that it might substitute for ADPH in milk lipid formation and secretion in ADPH-null mice. However, the patchy TIP47 staining pattern and the absence of TIP47 from some CLDs raised questions about its role in these processes.
Developmental TIP47 expression in ADPH-null mice ADPH expression has been shown to be closely linked to CLD accumulation in differentiating mammary glands Regulation of lipid formation and secretionof WT mice (5). We hypothesized that there would be a compensatory increase of TIP47 expression to correlate with these processes in ADPH-null mice. The size and number of CLDs in secretory epithelial cells in the mouse mammary gland have been shown previously to increase dramatically in conjunction with alveolar differentiation during late pregnancy and then to decrease once lactation is initiated after parturition (5). We obtained similar results in the ADPH-null mouse; confocal microscopy using Nomarski optics ( Fig. 2A, panels e-h) shows that by PCD 18 (the day before parturition in our colony), the cytoplasm of alveolar epithelial cells is filled with large CLDs, often with diameters in excess of 10 mm (Fig. 2A,  panel f) . Within 24 h after parturition (PCD 20), secretory epithelial cells contained smaller CLDs, many of which were observed to be adjacent to the apical border ( Fig. 2A,  panel g ). Immunofluorescence analysis of these sections showed intense TIP47 staining of CLDs in secretory epithelial cells at PCD 18 ( Fig. 2A, panel b) . However, by PCD 20, the staining was less prominent and many CLDs were not positive for TIP47 ( Fig. 2A, panel c) . By midlactation (PCD 29), relatively few CLDs stained for TIP47 ( Fig. 2A, panel d) .
To determine whether TIP47 staining of CLDs correlates with its tissue levels, we characterized TIP47 protein and mRNA levels in mammary glands of differentiating and lactating ADPH-null mice. Figure 2B shows that relative TIP47 protein levels in ADPH-null animals increased ?6-fold between PCD 10 and PCD 16 and then decreased steadily, so that by PCD 29 they were ?8% of the PCD 16 values. In contrast, TIP47 protein levels in mammary glands of WT mice changed relatively little during pregnancy and increased ?6-fold between PCD 18 and PCD 29. These changes in TIP47 protein levels in both WT and ADPH-null mice appear to be mediated by translational or posttranslational processes, as mammary gland TIP47 mRNA levels were similar and increased during mammary gland differentiation and lactation in both lines of mice (Fig. 2C) . These results suggest that TIP47 can associate with CLDs and that the protein level is high enough during pregnancy to associate with CLDs in the absence of WT ADPH. However, these findings and the immunocytochemistry results in Fig. 2A suggest that the protein is not directly related to lipid secretion during lactation in either WT or mutant mice.
ADPH-null mice express an N-terminally truncated form of ADPH
ADPH-null mice were generated by replacing exons 2 (which contains the translation start site) and 3 of the ADPH gene with a neo cassette, and on the basis of Northern analysis and immunoblot studies with an N-terminal antibody they were thought to be ADPH-null. However, in the process of exploring other possible explanations for relatively unaffected milk lipid formation and secretion in these mice, we noted that the disrupted ADPH gene sequence possessed a potential start site in exon 5 (Fig. 3A) . This raised the possibility that a truncated form of ADPH might be synthesized. To test this possibility, we generated antibodies against amino acids 409-425 (the C terminus) of mouse ADPH. Figure 3B shows immunoblots of mammary gland extracts from WT and ADPH-null mice at lactation day 10 using C-and N-terminal-specific antibodies. As expected, N-terminal antibodies detected a single band at ?50 kDa in WT mammary glands but failed to detect any bands in extracts from ADPH-null mammary glands. In contrast, C-terminal antibodies detected both the 50 kDa band and a lower molecular mass band in extracts of WT mammary glands (Fig. 3B, small  arrows) , whereas only the lower molecular mass band was detected in extracts of ADPH-null mammary glands (a nonspecific band near 75 kDa is detected in some extracts). Immunofluorescence analysis (Fig. 3C) verified that the C-terminal antibodies selectively stained CLDs in sections from lactating WT and ADPH-null glands and that in both cases staining was blocked by preincubating the antibodies with the immunizing peptide before staining.
To further test the possibility that a translatable product can be obtained from exons 4-8 of mouse ADPH, we stably transfected HEK293 cells, which lack endogenous ADPH (unpublished observations), with a plasmid that expresses cDNA corresponding to these exons linked at its 3 ¶ end to the coding sequence of the 11 amino acid VSVG monoclonal antibody epitope. Immunoblot analysis of extracts of these cells (D2,3-ADPH-VSV) using anti-VSVG antibodies shows that they produced a single protein species of approximately the same size as the lower molecular mass form of ADPH observed in extracts of WT and ADPH-null mammary glands (Fig. 3D) . Identical results were obtained using C-terminal-specific ADPH antibodies, whereas N-terminal-specific antibodies failed to detect any bands (data not shown). Immunofluorescence analysis of cells expressing the truncated form of ADPH (Fig. 3E) verified that it selectively localized to CLDs. Based on these results, the ADPH-null mutant mice appear to produce an N-terminally truncated form of ADPH that retains at least some functional properties. These mice will subsequently be referred to as D2,3 ADPH mice.
Truncated ADPH levels increase during mammary gland differentiation
To test the possibility that the N-terminally truncated form of APDH contributes to milk lipid formation and secretion, mammary gland sections from pregnant and lactating WT and D2,3 ADPH mice were stained with Cterminal-specific ADPH antibodies (Fig. 4A) . Corroborating previous studies (5), prominent large ADPH-positive CLDs were detected in secretory epithelial cells in WT mammary glands beginning around PCD 16; they completely filled these cells by PCD 18 (Fig. 4A, top panels) . During lactation, ADPH-positive CLDs were seen adjacent to apical membranes of secretory epithelial cells and in the luminal space of alveoli in WT animals soon after parturition (PCD 21) and at midlactation (PCD 29) (Fig. 4A,  top panels) . In contrast, ADPH-positive CLDs were not detected in secretory epithelial cells of D2,3 ADPH mice at PCD 16 and were seen only occasionally in these cells at PCD 18 (Fig. 4A, bottom panels) . However, ADPH-positive CLDs were detected in secretory epithelial cells of D2,3 ADPH mice after parturition (PCD 21), and numerous ADPH-positive CLDs were observed adjacent to apical membranes of secretory membranes of epithelial cells and in the luminal space of their alveoli by PCD 29, which suggests that they undergo secretion as milk fat globules. Immunoblots of differentiating and mature mammary gland tissue showed that ADPH levels correlated with the appearance of ADPH-positive CLDs in both WT mice (Fig. 4B) and D2,3 ADPH mice (Fig. 4C) . Importantly, the timing of the appearance of truncated ADPH in mammary tissue correlates with the onset of CLD secretion in D2,3 ADPH mice.
To determine whether the apparent delay in the appearance of truncated ADPH in D2,3 ADPH mouse mammary glands was related to delayed expression, we quantified ADPH transcript levels in mammary tissue of pregnant and lactating WT and D2,3 ADPH mice (Fig. 4D) . Using primers directed at exon boundaries 4 and 5 (Table 1) , we found that ADPH transcript levels increased significantly between PCD 12 and PCD 16 in both WT and D2,3 ADPH mice (Fig. 4D) ; however, transcript levels in D2,3 ADPH mice were 5% or less than those of WT mice. In addition, ADPH transcript in mammary tissue of WT mice increased into lactation (Fig. 4D, left axis) , whereas transcript levels in D2,3 ADPH mice (Fig. 4D , right axis) decreased sharply between the end of pregnancy (PCD 18) and day 2 of lactation (PCD 21) (Fig. 4D, arrow) . These results indicate that the delayed appearance of truncated ADPH in D2,3 ADPH mammary tissue is not the result of delayed ADPH expression and further suggest that translational and/or posttranslational mechanisms contribute to the increase in the levels of truncated ADPH in lactating mammary tissue.
DISCUSSION
We provide evidence that D2,3 ADPH mice, which were originally thought to lack ADPH (25, 31) , produce an N-terminally truncated form of ADPH that retains at least some of the functional properties of the full-length molecule. These mice were generated by replacing exons 2 and 3 of the mouse ADPH gene with a neo cassette. Based on the structure of the mouse ADPH gene (www. ensembl.org), the disrupted gene is postulated to lack the portion of the 5 ¶ untranslated region encoded by exon 2 and nucleotides encoding amino acids 1-75, but it may retain promoter elements and the 5 ¶ untranslated region encoded by exon 1 as well as exons 4-8. It was originally concluded, using Northern analysis and immunoblotting with N-terminal-specific ADPH antibodies, that the disrupted gene failed to produce ADPH transcripts or a translated product (25, 31) . However, our QRT-PCR analysis of mammary tissue using primers targeted to the exon 4-5 boundary of mouse ADPH shows that ADPH transcripts are present and that their levels are influenced by the developmental status of the mammary gland. These findings were confirmed by RT-PCR analysis with primers directed at exons 4 and 5 (data not shown) and indicate that the neo-disrupted ADPH gene retains the ability to undergo regulated transcription. Nevertheless, the observation that ADPH transcript levels in D2,3 ADPH mammary tissues are only a fraction of those in WT tissue suggests that ADPH expression is markedly reduced in D2,3 ADPH mice. At present, studies are under way to determine whether this reduction is attributable to diminished transcriptional efficiency of the mutated gene or decreased transcript stability.
The conclusion that neo-disrupted ADPH gene transcripts are translated is based on observations that C-terminalspecific ADPH antibodies detect a lower molecular mass band of similar size in extracts of D2,3 ADPH mouse mammary glands (Fig. 3B ) and HEK293 cells expressing cDNA corresponding to exons 4-8 of mouse ADPH (Fig. 3C) . Importantly, the cDNA construct used for our cell culture studies was generated to exactly match the sequence corresponding to exons 4-8 and therefore was constructed without an initiating ATG start site. Thus, any product generated from this construct had to be initiated from an internal start site. Although the position of the initiating methionine was not identified, translation appears to be initiated from a single site, because only a single lower molecular mass product is observed in both mammary tissue and cell culture extracts. Inspection of exons 4-8 for possible start sites showed that only the ATG encoding methionine 123 in exon 5 appeared to resemble a Kozak element (35) . However, other potential ATG sequences are present in exons 4-8, and efforts are currently under way to identify the position of the initiating methionine.
Use of the antibody to the C terminus of ADPH indicates that WT mammary tissue possesses a lower molecular mass form of ADPH that is similar in size to the forms found in extracts of D2,3 ADPH mammary tissue and D2,3 ADPH cells. This observation corroborates earlier data from our laboratory demonstrating the presence of a single lower molecular mass form of ADPH by mass spectrometry on CLDs isolated from lactating WT mouse mammary alveoli and in the membrane fraction from secreted fat globules (15) . Our present data indicate that this truncated form of ADPH does not appear until late pregnancy in WT and D2,3 ADPH mice and that its appearance lags behind the appearance of both fulllength ADPH protein and ADPH transcripts. Although it is possible that the lower molecular mass form is a proteolytic product of full-length ADPH, the presence of a possible translation initiation site in exon 5 raises the intriguing possibility that it represents an alternatively translated product whose expression is regulated differently from that of the full-length product. This notion is further supported by the observation that the lower molecular mass form was not associated with CLDs isolated from liver tissue (15) .
The possibility that truncated ADPH contributes to CLD formation and secretion in lactating D2,3 ADPH mice is suggested by our immunofluorescence data showing that it localizes to CLDs in both secretory epithelial cells and secreted milk fat globules in lactating D2,3 ADPH mice (Figs. 3C, 4A ) as well as to CLDs in D2,3 ADPH cells (Fig. 3E ). These observations, combined with our pre-vious mass spectrometry data, demonstrate that truncated ADPH can correctly localize to CLDs and that CLDs containing truncated ADPH can undergo secretion as milk fat globules. We have shown previously that ADPH forms a stable complex with xanthine oxidoreductase and butyrophilin on milk fat globule membranes (32) . Thus, the detection of truncated ADPH on milk fat globule membranes (data not shown) is consistent with the possibility that it may form similar functional interactions with these molecules and consequently contribute to CLD secretion, possibly explaining the relatively modest reduction in the milk fat content of D2,3 ADPH mice. Although the presence of a functionally active truncated form of ADPH may also explain the limited phenotype observed in liver and fibroblasts of D2,3 ADPH mice (25, 31) , preliminary RT-PCR data using primers targeted to exons 4 and 5 in the liver detected no truncated ADPH transcripts compared with the mammary gland (data not shown). It is currently unclear whether this is attributable to tissuespecific transcriptional regulation or to the known instability of RNA isolated from the liver.
Our current findings are consistent with previous studies showing a close correlation between full-length ADPH expression and CLD accumulation in differentiating secretory epithelial cells of WT mice (5, 36) . However, truncated ADPH does not appear to contribute to this process in D2,3 ADPH mice, as only limited amounts of truncated ADPH are present in their mammary glands before parturition, despite the presence of numerous large CLDs in their secretory epithelial cells during late pregnancy. Moreover, these large CLDs fail to show significant ADPH staining with antibodies specific to either N-terminal or C-terminal sequences of mouse ADPH. In contrast, observations that TIP47 levels increase in mammary glands of D2,3 ADPH mice during mammary gland differentiation, and that large TIP47-postive CLDs are present in secretory epithelial cells of these mice during late pregnancy, suggest that it many mediate CLD accumulation in differentiating D2,3 ADPH mammary glands. These data corroborate recent studies demonstrating that TIP47 localizes to CLDs in embryonic fibroblasts from D2,3 ADPH mice (25) and are consistent with the hypothesis that it contributes to CLD formation when ADPH is lacking (25) . However, the dramatic decline in mammary gland TIP47 levels after parturition, and the reduction of TIP47 staining of CLDs in secretory epithelial cells of lactating D2,3 ADPH mice, raise questions about whether it plays a similar role in the formation and secretion of milk lipids during lactation. Indeed, the reciprocal relationship between TIP47 and truncated ADPH levels observed in differentiating and lactating D2,3 ADPH mammary tissues suggests that CLD accumulation in these mice may involve independent and stage-specific actions of both molecules, with TIP47 regulating CLD accumulation in differentiating D2,3 ADPH mammary glands and truncated ADPH regulating CLD formation and secretion in lactating mammary glands.
Studies by Sztalryd et al. (25) in embryonic fibroblasts from D2,3 ADPH demonstrated that the loss of ADPH resulted in apparent compensatory increases in transcript and protein levels of TIP47, which suggested that the expression of these proteins may be inversely related. Consistent with this concept, we found that TIP47 levels in D2,3 ADPH mammary glands were increased over those of WT glands during the period of mammary gland differentiation, when the truncated form of ADPH was not detectable, and that as the levels of truncated ADPH increased during lactation, the levels of TIP47 in D2,3 ADPH mammary glands declined. In contrast to embryonic fibroblasts, transcript levels of TIP47 in D2,3 ADPH mammary glands did not differ from those in WT mammary glands, which suggests that if functional compensation exists between ADPH and TIP47 in the mammary gland, it is regulated by posttranscriptional mechanisms. However, it is important to note that in WT mammary glands, both ADPH and TIP47 levels increase during lactation. Thus, functional compensation between these proteins may not be a general property of all tissues and may be influenced by both developmental and tissuespecific factors.
In summary, our results show that lactating mammary glands of D2,3 ADPH mice produce an N-terminally truncated form of ADPH with the necessary expression and localization properties to function in the formation and secretion of milk lipids. Although previous studies have documented that the N-terminal region is not required for targeting ADPH to CLDs in transient transfection models (33, 37) , our study provides the first in vivo evidence that the N-terminal region of ADPH may not be required for its activity. Our data also provide in vivo evidence for the hypothesis that TIP47 can compensate for the loss of ADPH in CLD accumulation in differentiating mammary glands. Although detailed understanding of the physiological functions of ADPH and TIP47 in milk lipid formation and secretion will require complete functional knockouts of one or both molecules, D2,3 ADPH mice provide a potentially useful model to identify the molecular interactions that govern interactions between ADPH and other molecules involved in milk lipid formation.
